On the basis of these results, we reasonably speculate that recurrent/refractory B-NHL cells show high expression of B7-H7, which activates the intracellular PI3K/AKT pathway, leading to the promotion of tumor progression and induction of resistance to RTX. The gene discussed is HHLA2; the disease is neoplasm.